IDRSF (Idorsia) Price-to-Tangible-Book : (As of Dec. 12, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Price-to-Tangible-Book?

As of today (2024-12-12), Idorsia's share price is $1.50. Idorsia's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $-7.16. Hence, Idorsia's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Idorsia's Price-to-Tangible-Book or its related term are showing as below:

During the past 8 years, Idorsia's highest Price to Tangible Book Ratio was 58.52. The lowest was 2.88. And the median was 7.26.

IDRSF's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.93
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Idorsia's share price is $1.50. Idorsia's Book Value per Sharefor the quarter that ended in Sep. 2024 was $-7.06. Hence, Idorsia's P/B Ratio of today is .

Idorsia Price-to-Tangible-Book Historical Data

The historical data trend for Idorsia's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Price-to-Tangible-Book Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

23.71

7.26

34.70

Idorsia Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Idorsia's Price-to-Tangible-Book

For the Biotechnology subindustry, Idorsia's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Idorsia's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Idorsia's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Idorsia's Price-to-Tangible-Book falls into.

Idorsia Price-to-Tangible-Book Calculation

Idorsia's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2024 )
	=	1.50	/	-7.16
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Idorsia Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Idorsia's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

IDIAz:UK 0RQE:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.